Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Logo for

Science 310 (5751): 1159-1163

Copyright © 2005 by the American Association for the Advancement of Science

Structure of the Quaternary Complex of Interleukin-2 with Its {alpha}, ß, and {gamma}c Receptors

Xinquan Wang,* Mathias Rickert,* K. Christopher Garcia{dagger}

Abstract: Interleukin-2 (IL-2) is an immunoregulatory cytokine that acts through a quaternary receptor signaling complex containing alpha (IL-2R{alpha}), beta (IL-2Rß), and common gamma chain (gc) receptors. In the structure of the quaternary ectodomain complex as visualized at a resolution of 2.3 angstroms, the binding of IL-2R{alpha} to IL-2 stabilizes a secondary binding site for presentation to IL-2Rß. {gamma}c is then recruited to the composite surface formed by the IL-2/IL-2Rß complex. Consistent with its role as a shared receptor for IL-4, IL-7, IL-9, IL-15, and IL-21, {gamma}c forms degenerate contacts with IL-2. The structure of {gamma}c provides a rationale for loss-of-function mutations found in patients with X-linked severe combined immunodeficiency diseases (X-SCID). This complex structure provides a framework for other {gamma}c-dependent cytokine-receptor interactions and for the engineering of improved IL-2 therapeutics.

Howard Hughes Medical Institute, Department of Microbiology and Immunology, and Department of Structural Biology, Stanford University School of Medicine, 299 Campus Drive, Fairchild D319, Stanford, CA 94305, USA.

* These authors contributed equally to this work.

{dagger} To whom correspondence should be addressed. E-mail: kcgarcia{at}stanford.edu

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease.
K.-i. Matsuoka, J. Koreth, H. T. Kim, G. Bascug, S. McDonough, Y. Kawano, K. Murase, C. Cutler, V. T. Ho, E. P. Alyea, et al. (2013)
Science Translational Medicine 5, 179ra43
   Abstract »    Full Text »    PDF »
Membrane Microdomains and Cytoskeleton Organization Shape and Regulate the IL-7 Receptor Signalosome in Human CD4 T-cells.
B. Tamarit, F. Bugault, A.-H. Pillet, V. Lavergne, P. Bochet, N. Garin, U. Schwarz, J. Theze, and T. Rose (2013)
J. Biol. Chem. 288, 8691-8701
   Abstract »    Full Text »    PDF »
Cell-to-Cell Variability Analysis Dissects the Plasticity of Signaling of Common {gamma} Chain Cytokines in T Cells.
J. W. Cotari, G. Voisinne, O. E. Dar, V. Karabacak, and G. Altan-Bonnet (2013)
Science Signaling 6, ra17
   Abstract »    Full Text »    PDF »
Crystal Structure of Interleukin-21 Receptor (IL-21R) Bound to IL-21 Reveals That Sugar Chain Interacting with WSXWS Motif Is Integral Part of IL-21R.
O. J. Hamming, L. Kang, A. Svensson, J. L. Karlsen, H. Rahbek-Nielsen, S. R. Paludan, S. A. Hjorth, K. Bondensgaard, and R. Hartmann (2012)
J. Biol. Chem. 287, 9454-9460
   Abstract »    Full Text »    PDF »
Structural reorganization of the interleukin-7 signaling complex.
C. A. McElroy, P. J. Holland, P. Zhao, J.-M. Lim, L. Wells, E. Eisenstein, and S. T. R. Walsh (2012)
PNAS 109, 2503-2508
   Abstract »    Full Text »    PDF »
Interleukin-2 signalling is modulated by a labile disulfide bond in the CD132 chain of its receptor.
C. Metcalfe, P. Cresswell, and A. N. Barclay (2012)
Open Bio 2, 110036
   Abstract »    Full Text »    PDF »
Evolution of interleukin-15 for higher E. coli expression and solubility.
G. Behar, V. Sole, A. Defontaine, M. Maillasson, A. Quemener, Y. Jacques, and C. Tellier (2011)
Protein Eng. Des. Sel. 24, 283-290
   Abstract »    Full Text »    PDF »
Forced Homo- and Heterodimerization of All gp130-Type Receptor Complexes Leads to Constitutive Ligand-independent Signaling and Cytokine-independent Growth.
J. Suthaus, A. Tillmann, I. Lorenzen, E. Bulanova, S. Rose-John, and J. Scheller (2010)
Mol. Biol. Cell 21, 2797-2807
   Abstract »    Full Text »    PDF »
Ectodomain Shedding of Interleukin-2 Receptor {beta} and Generation of an Intracellular Functional Fragment.
P. M. de Oca B., V. Malarde, R. Proust, A. Dautry-Varsat, and F. Gesbert (2010)
J. Biol. Chem. 285, 22050-22058
   Abstract »    Full Text »    PDF »
An IL-2 Paradox: Blocking CD25 on T Cells Induces IL-2-Driven Activation of CD56bright NK Cells.
J. F. Martin, J. S. A. Perry, N. R. Jakhete, X. Wang, and B. Bielekova (2010)
J. Immunol. 185, 1311-1320
   Abstract »    Full Text »    PDF »
Rational Design of Interleukin-21 Antagonist through Selective Elimination of the {gamma}C Binding Epitope.
L. Kang, K. Bondensgaard, T. Li, R. Hartmann, and S. A. Hjorth (2010)
J. Biol. Chem. 285, 12223-12231
   Abstract »    Full Text »    PDF »
Structural Basis for the Blockage of IL-2 Signaling by Therapeutic Antibody Basiliximab.
J. Du, H. Yang, D. Zhang, J. Wang, H. Guo, B. Peng, Y. Guo, and J. Ding (2010)
J. Immunol. 184, 1361-1368
   Abstract »    Full Text »    PDF »
Novel Human Interleukin-15 Agonists.
X. Zhu, W. D. Marcus, W. Xu, H.-i. Lee, K. Han, J. O. Egan, J. L. Yovandich, P. R. Rhode, and H. C. Wong (2009)
J. Immunol. 183, 3598-3607
   Abstract »    Full Text »    PDF »
Dimerization of Kit-ligand and efficient cell-surface presentation requires a conserved Ser-Gly-Gly-Tyr motif in its transmembrane domain.
F. Paulhe, M. Wehrle-Haller, M.-C. Jacquier, B. A. Imhof, S. Tabone-Eglinger, and B. Wehrle-Haller (2009)
FASEB J 23, 3037-3048
   Abstract »    Full Text »    PDF »
The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease.
T. R. Hercus, D. Thomas, M. A. Guthridge, P. G. Ekert, J. King-Scott, M. W. Parker, and A. F. Lopez (2009)
Blood 114, 1289-1298
   Abstract »    Full Text »    PDF »
Ligand-independent Homomeric and Heteromeric Complexes between Interleukin-2 or -9 Receptor Subunits and the {gamma} Chain.
Y. Malka, T. Hornakova, Y. Royer, L. Knoops, J.-C. Renauld, S. N. Constantinescu, and Y. I. Henis (2008)
J. Biol. Chem. 283, 33569-33577
   Abstract »    Full Text »    PDF »
Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity.
H. P. Carroll, V. Paunovic, and M. Gadina (2008)
Rheumatology 47, 1269-1277
   Abstract »    Full Text »    PDF »
IL-2 Receptor {beta}-Chain Signaling Controls Immunosuppressive CD4+ T Cells in the Draining Lymph Nodes and Lung during Allergic Airway Inflammation In Vivo.
A. Doganci, R. Karwot, J. H. Maxeiner, P. Scholtes, E. Schmitt, M. F. Neurath, H. A. Lehr, I-C. Ho, and S. Finotto (2008)
J. Immunol. 181, 1917-1926
   Abstract »    Full Text »    PDF »
Crystal Structure of the Interleukin-15{middle dot}Interleukin-15 Receptor {alpha} Complex: INSIGHTS INTO TRANS AND CIS PRESENTATION.
S. K. Olsen, N. Ota, S. Kishishita, M. Kukimoto-Niino, K. Murayama, H. Uchiyama, M. Toyama, T. Terada, M. Shirouzu, O. Kanagawa, et al. (2007)
J. Biol. Chem. 282, 37191-37204
   Abstract »    Full Text »    PDF »
Interleukin-21 Signaling: Functions in Cancer and Autoimmunity.
I. D. Davis, K. Skak, M. J. Smyth, P. E.G. Kristjansen, D. M. Miller, and P. V. Sivakumar (2007)
Clin. Cancer Res. 13, 6926-6932
   Abstract »    Full Text »    PDF »
The Existence of Multiple Conformers of Interleukin-21 Directs Engineering of a Superpotent Analogue.
K. Bondensgaard, J. Breinholt, D. Madsen, D. H. Omkvist, L. Kang, A. Worsaae, P. Becker, C. B. Schiodt, and S. A. Hjorth (2007)
J. Biol. Chem. 282, 23326-23336
   Abstract »    Full Text »    PDF »
Identification of Their Epitope Reveals the Structural Basis for the Mechanism of Action of the Immunosuppressive Antibodies Basiliximab and Daclizumab.
M. Binder, F.-N. Vogtle, S. Michelfelder, F. Muller, G. Illerhaus, S. Sundararajan, R. Mertelsmann, and M. Trepel (2007)
Cancer Res. 67, 3518-3523
   Abstract »    Full Text »    PDF »
Toward Further Mapping of the Association Between the IL2RA Locus and Type 1 Diabetes.
H.-Q. Qu, A. Montpetit, B. Ge, T. J. Hudson, and C. Polychronakos (2007)
Diabetes 56, 1174-1176
   Abstract »    Full Text »    PDF »
Conformational Changes Mediate Interleukin-10 Receptor 2 (IL-10R2) Binding to IL-10 and Assembly of the Signaling Complex.
S. I. Yoon, N. J. Logsdon, F. Sheikh, R. P. Donnelly, and M. R. Walter (2006)
J. Biol. Chem. 281, 35088-35096
   Abstract »    Full Text »    PDF »
Hot-spot mimicry of a cytokine receptor by a small molecule.
C. D. Thanos, W. L. DeLano, and J. A. Wells (2006)
PNAS 103, 15422-15427
   Abstract »    Full Text »    PDF »
Anti-CD25 Antibody Treatment of Mice Vaccinated and Challenged with Borrelia spp. Does Not Exacerbate Arthritis but Inhibits Borreliacidal Antibody Production.
D. T. Nardelli, T. F. Warner, S. M. Callister, and R. F. Schell (2006)
Clin. Vaccine Immunol. 13, 884-891
   Abstract »    Full Text »    PDF »
Modulation by IL-2 of CD70 and CD27 Expression on CD8+ T Cells: Importance for the Therapeutic Effectiveness of Cell Transfer Immunotherapy..
J. Huang, K. W. Kerstann, M. Ahmadzadeh, Y. F. Li, M. El-Gamil, S. A. Rosenberg, and P. F. Robbins (2006)
J. Immunol. 176, 7726-7735
   Abstract »    Full Text »    PDF »
The Structure of the Interleukin-15{alpha} Receptor and Its Implications for Ligand Binding.
I. Lorenzen, A. J. Dingley, Y. Jacques, and J. Grotzinger (2006)
J. Biol. Chem. 281, 6642-6647
   Abstract »    Full Text »    PDF »
Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor.
D. J. Stauber, E. W. Debler, P. A. Horton, K. A. Smith, and I. A. Wilson (2006)
PNAS 103, 2788-2793
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882